Published 2019 | Version v1
Miscellaneous

Development and optimization of functionalized gold-198 nanoparticles for use in cancer therapy

  • 1. McMaster Univ., Hamilton, ON (Canada)
  • 2. Univ. of Waterloo, Kitchener, ON (Canada)
  • 3. Grand River Hospital, Kitchener, ON (Canada)
  • 4. Univ. of Guelph, Ontario Veterinary College, Guelph, ON (Canada)

Description

Gold nanoparticles (AuNPs) have multifaceted applications in imaging, diagnostics, and as drug delivery agents. Coating AuNPs in natural products such as nutraceuticals increases the biomedical applications by imparting anti-inflammatory, anti-oxidant, and anti-cancer properties; moreover, the inclusion of the radioisotope gold-198 (t½ = 2.7 d, Eβmax = 0.96 MeV, Eγ = 411 keV) can convert functionalized AuNPs into radiotherapeutic agents. However, synthetic routes to AuNPs are not amenable to radiochemical synthesis because they require excess gold, long synthesis times, and large waste volumes. The objective of this study was to develop and optimize a route to 198AuNPs functionalized with various organic coatings. A procedure was developed that enabled the synthesis to be completed in less than 3 h, with a radiochemical yield of >99%. The method validation will be presented, along with stability studies of the 198AuNPs at physiological appropriate pH, and next steps toward translating these nanoparticles into a cancer therapeutic. (author)

Availability note (English)

Available as a slide presentation only
Part of:
Nuclear energy's value: aligned with community expectations. 39th Annual CNS conference and 43rd CNS/CNA student conference

Additional details

Publishing Information

Publisher
Canadian Nuclear Society
Imprint Place
Toronto, Ontario (Canada)
ISBN
978-1-926773-28-5
Imprint Title
Nuclear energy's value: aligned with community expectations. 39th Annual CNS conference and 43rd CNS/CNA student conference
Imprint Pagination
175 Megabytes
Journal Page Range
[7 p.]

Conference

Title
39. Annual CNS conference and 43. CNS/CNA student conference
Dates
23-26 Jun 2019
Place
Ottawa, Ontario (Canada)

Optional Information

Notes
4 refs. 7 figs.